![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
Hidehito HORINOUCHI
@HHorinouchi
Medical Oncologist, NCC Japan, Lung Cancer Study Group @JCOG_official, Education committee @JSMO_official @JLCS_OFFICIAL @IASLC @ASCO FCOI https://t.co/c9VKywVghP
ID:149859004
https://www.linkedin.com/in/hidehito-horinouchi-679b3548/ 30-05-2010 12:17:24
1,3K Tweets
1,5K Followers
110 Following
![IASLC(@IASLC) 's Twitter Profile Photo IASLC(@IASLC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1760755879920721920/Hb7p-RrG_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
🔥COPILOT: Completion Of Pembrolizumab In advanced NSCLC
🎙️Dr. A Fantoni Clinical Lung Cancer
🎯Real world Outcomes after Two years of therapy ()
✅Observational study
✅Primary: PFS
✅AUstralian Registry and biObank of thoRacic cAncers (AURORA)
#LCSM OncoAlert
clinical-lung-cancer.com/article/S1525-…
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![ASCO(@ASCO) 's Twitter Profile Photo ASCO(@ASCO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768689771818188801/VfrMhROq_200x200.png)
![Nature Medicine(@NatureMedicine) 's Twitter Profile Photo Nature Medicine(@NatureMedicine) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1187090658248540161/GQ33i4Hv_200x200.jpg)
⚡Our April issue is live! Featuring studies on #cancer #vaccines & #neoadjuvant therapy, clinical #AI , an #AlzheimersDisease blood test, telehealth #abortion , #ParkinsonsDisease , #T2D , and much more including news, reviews & opinion.
nature.com/nm/volumes/30/…
![Nature Medicine (@NatureMedicine) on Twitter photo 2024-04-19 17:15:23 ⚡Our April issue is live! Featuring studies on #cancer #vaccines & #neoadjuvant therapy, clinical #AI, an #AlzheimersDisease blood test, telehealth #abortion, #ParkinsonsDisease, #T2D, and much more including news, reviews & opinion. nature.com/nm/volumes/30/… ⚡Our April issue is live! Featuring studies on #cancer #vaccines & #neoadjuvant therapy, clinical #AI, an #AlzheimersDisease blood test, telehealth #abortion, #ParkinsonsDisease, #T2D, and much more including news, reviews & opinion. nature.com/nm/volumes/30/…](https://pbs.twimg.com/media/GLizgnnWQAAsfjD.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
Dr. Xiuning Le MD PhD at #TexasLung24 gives a brilliant breakdown of frontline #EGFR combination strategies including adding amivantamab to TKI (MARIPOSA) and targeting VEGF (RAMOSE). TLC Conference
![Stephen V Liu, MD (@StephenVLiu) on Twitter photo 2024-04-19 19:20:31 Dr. @LeXiuning at #TexasLung24 gives a brilliant breakdown of frontline #EGFR combination strategies including adding amivantamab to TKI (MARIPOSA) and targeting VEGF (RAMOSE). @TLCconference Dr. @LeXiuning at #TexasLung24 gives a brilliant breakdown of frontline #EGFR combination strategies including adding amivantamab to TKI (MARIPOSA) and targeting VEGF (RAMOSE). @TLCconference](https://pbs.twimg.com/media/GLjQCckW4AAyeYF.jpg)
![Ben Solomon(@bensolomon1) 's Twitter Profile Photo Ben Solomon(@bensolomon1) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1603513472494743552/a_kdlbNT_200x200.jpg)
A timely discussion with Narjust Florez, MD, FASCO amazing host of @iaslc Lung Cancer Considered podcast about the ALINA trial given the recent U.S. FDA approval of adjuvant alectinib for resected ALK+ NSCLC! Thanks Narjust Florez, MD, FASCO ! #LCSM
![IASLC(@IASLC) 's Twitter Profile Photo IASLC(@IASLC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1760755879920721920/Hb7p-RrG_200x200.jpg)
In the wake of the U.S. FDA approval of alectinib for resected #NSCLC , host Narjust Florez, MD, FASCO & guest Ben Solomon discuss this development & take a deeper look at the ALINA trial, which included pts w/resected stage II/III NSCLC w/an ALK fusion: bit.ly/AlectinibFDA24 #LCSM
![IASLC (@IASLC) on Twitter photo 2024-04-19 15:03:15 In the wake of the @US_FDA approval of alectinib for resected #NSCLC, host @NarjustFlorezMD & guest @bensolomon1 discuss this development & take a deeper look at the ALINA trial, which included pts w/resected stage II/III NSCLC w/an ALK fusion: bit.ly/AlectinibFDA24 #LCSM In the wake of the @US_FDA approval of alectinib for resected #NSCLC, host @NarjustFlorezMD & guest @bensolomon1 discuss this development & take a deeper look at the ALINA trial, which included pts w/resected stage II/III NSCLC w/an ALK fusion: bit.ly/AlectinibFDA24 #LCSM](https://pbs.twimg.com/media/GLiVQ8uXAAEdXUR.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![OncoAlert(@OncoAlert) 's Twitter Profile Photo OncoAlert(@OncoAlert) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1215669650333323266/z8agvcHA_200x200.jpg)
Just Out
U.S. FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA
fda.gov/drugs/resource…
Christian Rolfo gilberto lopes Narjust Florez, MD, FASCO Stephen V Liu, MD H. Jack West, MD
![OncoAlert (@OncoAlert) on Twitter photo 2024-04-19 04:49:53 Just Out @US_FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA fda.gov/drugs/resource… @ChristianRolfo @GlopesMd @NarjustFlorezMD @StephenVLiu @JackWestMD Just Out @US_FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA fda.gov/drugs/resource… @ChristianRolfo @GlopesMd @NarjustFlorezMD @StephenVLiu @JackWestMD](https://pbs.twimg.com/media/GLgI32YWoAEngYt.jpg)
![IASLC(@IASLC) 's Twitter Profile Photo IASLC(@IASLC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1760755879920721920/Hb7p-RrG_200x200.jpg)
![Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation(@RManochakian) 's Twitter Profile Photo Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation(@RManochakian) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1362619060077363204/_LEQ5AsX_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1748532107109126144/bMCo1yrB_200x200.jpg)
![OncoAlert(@OncoAlert) 's Twitter Profile Photo OncoAlert(@OncoAlert) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1215669650333323266/z8agvcHA_200x200.jpg)
Just out by our OncoAlert 🚨 #LungCancer Faculty Christian Rolfo 🇺🇸and team
Study suggests circulating tumor DNA (ctDNA)🧬 tumor fraction (TF) could enhance liquid biopsy accuracy in detecting true negative results
✅Aiding in decision-making for follow-up tissue testing in
![OncoAlert (@OncoAlert) on Twitter photo 2024-04-17 13:29:44 Just out by our @OncoAlert 🚨 #LungCancer Faculty @ChristianRolfo 🇺🇸and team Study suggests circulating tumor DNA (ctDNA)🧬 tumor fraction (TF) could enhance liquid biopsy accuracy in detecting true negative results ✅Aiding in decision-making for follow-up tissue testing in Just out by our @OncoAlert 🚨 #LungCancer Faculty @ChristianRolfo 🇺🇸and team Study suggests circulating tumor DNA (ctDNA)🧬 tumor fraction (TF) could enhance liquid biopsy accuracy in detecting true negative results ✅Aiding in decision-making for follow-up tissue testing in](https://pbs.twimg.com/media/GLXsV65WcAAVQTU.png)